Butofilolol
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
(RS)-1-[2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl]butan-1-one
|
|
| Identifiers | |
| CAS Number | 64552-17-6  |
| ATC code | none |
| PubChem | CID 68838 |
| ChemSpider | 62071  |
| UNII | 4AZC6Y5A8G |
| ChEMBL | CHEMBL157443 |
| Synonyms | CM-6805 |
| Chemical data | |
| Formula | C17H26FNO3 |
| Molar mass | 311.392 g/mol |
|
|
|
|
| (what is this?) (verify) |
Butofilolol (trade name Cafide) is a beta-blocker drug for the treatment of essential hypertension (high blood pressure).[1][2] It is not known to be marketed anywhere.
References[edit]
- ^ Houin, G; Barre, J; Jeanniot, JP; Ledudal, P; Cautreels, W; Tillement, JP (1984). "Pharmacokinetics of butofilolol (CAFIDE) after repeated oral administration in man". International journal of clinical pharmacology research 4 (3): 175–83. PMID 6149195.
- ^ Toussain, P; Gay, G; Debry, G (1983). "Long-term hypotensive treatment by butofilolol". Annales de cardiologie et d'angeiologie 32 (4): 277–83. PMID 6412614.
 |
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
